58 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva inks early-stage drug research deals https://seekingalpha.com/news/3521812-teva-inks-early-stage-drug-research-deals?source=feed_news_all Nov 25, 2019 - Teva (NYSE:TEVA) is starting the week up 5.6% after signing research agreements with two leading Israeli academic institutes to boost its early-stage drug development.A partnership with Tel Aviv Unive
Why The Bear Attack On Teva Pharmaceutical Must End https://seekingalpha.com/article/4309342-bear-attack-teva-pharmaceutical-must-end?source=feed_tag_israel Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
Why The Bear Attack On Teva Pharmaceutical Must End https://seekingalpha.com/article/4309342-why-bear-attack-on-teva-pharmaceutical-must-end?source=feed_tag_israel Nov 26, 2019 - Renewed bearishness on Teva over the opioid subpoena may prove short-lived.Third-quarter results a positive inflection point.Business recovery underway.
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders http://www.zacks.com/stock/news/653885/jjs-jnj-new-tests-reveal-no-asbestos-in-baby-powders?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-653885 Dec 04, 2019 - J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
Bayer and Teva Double Down on Worst M&A Deals of Decade http://www.gurufocus.com/news/995213/bayer-and-teva-double-down-on-worst-ma-deals-of-decade Dec 04, 2019 - Bayer and Teva Double Down on Worst M&A Deals of Decade, Stocks: BAYN,TEVA,GILD,MRK,NVS,BMY,PFE,GSK,SHRS,SNY,AMGN,A, release date:Dec 03, 2019
Novartis Announces Positive Long-Term Data on Migraine Drug http://www.zacks.com/stock/news/509529/novartis-announces-positive-long-term-data-on-migraine-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-509529 Sep 09, 2019 - Novartis' (NVS) migraine drug Aimovig is effective and safe in treating patients with episodic migraine in a long-term study.
Here Are the Last 3 Stocks I Bought -- and Why https://www.fool.com/investing/2019/09/12/here-are-the-last-3-stocks-i-bought-and-why.aspx?source=iedfolrf0000001 Sep 12, 2019 - Recent market volatility has created some compelling buying opportunities.
Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal http://feeds.benzinga.com/~r/benzinga/~3/6bq5pVqC7OA/teva-dips-into-medical-marijuana-market-with-canndoc-distribution-deal Sep 13, 2019 -

Cannabis companies have been feverishly stitching up partnerships with each other, beverage companies and biopharma companies to tap into the market's huge potential.

Israel-based Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has taken a giant leap of faith in this direction.

read more

Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know http://www.zacks.com/stock/news/521635/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-521635 Sep 16, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $8.04, moving +1.26% from the previous trading session.
J&J's Prostate Cancer Drug Gets FDA Nod for Expanded Use http://www.zacks.com/stock/news/526368/jjs-prostate-cancer-drug-gets-fda-nod-for-expanded-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526368 Sep 19, 2019 - J&J's (JNJ) sNDA seeking approval of Erleada for metastatic castration-sensitive prostate cancer is based on data from TITAN study.

Pages: 123456

<<<Page 3>